Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00163449
Status:
COMPLETED
Last Update Posted:
2016-12-08
First Post:
2005-09-12
Brief Title:
Efficacy and Safety of Ciclesonide in Preschool Children With Asthma 2 to 6 Years BY9010M1-207
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
BALLOON Efficacy and Safety - Study by ALTANA on Ciclesonide in Pre-school Asthma Patients
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the present study is to compare the efficacy of inhaled ciclesonide in pre-school children Ciclesonide will be inhaled once daily using one of three dose levels and tested versus placebo The study duration consists of a baseline period 2 to 4 weeks and a treatment period 24 weeks The study will provide further data on safety and tolerability of ciclesonide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None